EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 17th, 2022 • Prelude Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 17th, 2022 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), made between Prelude Therapeutics Incorporated, a Delaware corporation (the “Company”), and Laurent Chardonnet (“Executive” and, collectively with the Company, the “Parties”), is entered into as of 11/5/2021 | 5:16 PM EDT.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 17th, 2022 • Prelude Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 17th, 2022 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), made between Prelude Therapeutics Incorporated, a Delaware corporation (the “Company”), and Brian Piper (“Executive” and, collectively with the Company, the “Parties”), is entered into as of December 19, 2020 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 17th, 2022 • Prelude Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 17th, 2022 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), made between Prelude Therapeutics Incorporated, a Delaware corporation (the “Company”), and Peggy Scherle (“Executive” and, collectively with the Company, the “Parties”), is entered into as of December 19, 2020 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 17th, 2022 • Prelude Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 17th, 2022 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), made between Prelude Therapeutics Incorporated, a Delaware corporation (the “Company”), and Andrew Combs (“Executive” and, collectively with the Company, the “Parties”), is entered into as of December 19, 2020 (the “Effective Date”).